Search

Jill D. Martin

Examiner (ID: 8859)

Most Active Art Unit
1632
Art Unit(s)
1621, 1819, 1804, 1632
Total Applications
267
Issued Applications
131
Pending Applications
85
Abandoned Applications
51

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4407163 [patent_doc_number] => 06309848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Human xenografts for microbicide testing and anatomical modeling' [patent_app_type] => 1 [patent_app_number] => 9/624318 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9706 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309848.pdf [firstpage_image] =>[orig_patent_app_number] => 624318 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/624318
Human xenografts for microbicide testing and anatomical modeling Jul 23, 2000 Issued
Array ( [id] => 4316075 [patent_doc_number] => 06316689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => '25-hydroxyvitamin D3 24-hydroylase transgenic rats' [patent_app_type] => 1 [patent_app_number] => 9/423011 [patent_app_country] => US [patent_app_date] => 1999-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18916 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316689.pdf [firstpage_image] =>[orig_patent_app_number] => 423011 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/423011
25-hydroxyvitamin D3 24-hydroylase transgenic rats Oct 26, 1999 Issued
09/400497 HEPATITIS B CORE ANTIGEN NUCLEIC ACID VACCINE Sep 20, 1999 Abandoned
09/395368 EMBRYONIC OR STEM-LIKE CELL LINES PRODUCED BY CROSS SPECIES NUCLEAR TRANSPLANTATION AND METHODS FOR ENHANCING EMBRYONIC DEVELOPMENT BY GENETIC ALTERATION OF DONOR CELLS OR BY TISSUE CULTURE CONDITIONS Sep 13, 1999 Abandoned
09/356987 METHODS OF PREFORMING HOMOLOGOUS RECOMBINATION BASED MODIFICATION OF NUCLEIC ACIDS IN RECOMBINATION DEFICIENT CELLS AND USE OF THE MODIFIED NUCLEIC ACID PRODUCTS THEREOF Jul 19, 1999 Abandoned
Array ( [id] => 4302849 [patent_doc_number] => 06326205 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Methods for use of Mpl ligands with primitive human stem cells' [patent_app_type] => 1 [patent_app_number] => 9/328188 [patent_app_country] => US [patent_app_date] => 1999-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 15176 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326205.pdf [firstpage_image] =>[orig_patent_app_number] => 328188 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/328188
Methods for use of Mpl ligands with primitive human stem cells Jun 7, 1999 Issued
Array ( [id] => 4241899 [patent_doc_number] => 06166287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Corticotropin-releasing factor overproducing transgenic mice' [patent_app_type] => 1 [patent_app_number] => 9/325926 [patent_app_country] => US [patent_app_date] => 1999-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8438 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166287.pdf [firstpage_image] =>[orig_patent_app_number] => 325926 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/325926
Corticotropin-releasing factor overproducing transgenic mice Jun 3, 1999 Issued
Array ( [id] => 4275067 [patent_doc_number] => 06245966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Adenoviral mediated gene transfer into lymphocytes' [patent_app_type] => 1 [patent_app_number] => 9/272496 [patent_app_country] => US [patent_app_date] => 1999-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 8049 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245966.pdf [firstpage_image] =>[orig_patent_app_number] => 272496 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/272496
Adenoviral mediated gene transfer into lymphocytes Mar 18, 1999 Issued
Array ( [id] => 4320138 [patent_doc_number] => 06248725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction' [patent_app_type] => 1 [patent_app_number] => 9/256630 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8667 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248725.pdf [firstpage_image] =>[orig_patent_app_number] => 256630 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/256630
Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction Feb 22, 1999 Issued
Array ( [id] => 4409622 [patent_doc_number] => 06265390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements' [patent_app_type] => 1 [patent_app_number] => 9/253738 [patent_app_country] => US [patent_app_date] => 1999-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 6557 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265390.pdf [firstpage_image] =>[orig_patent_app_number] => 253738 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/253738
Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements Feb 21, 1999 Issued
Array ( [id] => 4310404 [patent_doc_number] => 06242182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Methods for haplotyping Rfp-Y and B-F genes in chicken' [patent_app_type] => 1 [patent_app_number] => 9/244093 [patent_app_country] => US [patent_app_date] => 1999-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5567 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242182.pdf [firstpage_image] =>[orig_patent_app_number] => 244093 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/244093
Methods for haplotyping Rfp-Y and B-F genes in chicken Feb 3, 1999 Issued
Array ( [id] => 4316117 [patent_doc_number] => 06316692 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies' [patent_app_type] => 1 [patent_app_number] => 9/191920 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9598 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316692.pdf [firstpage_image] =>[orig_patent_app_number] => 191920 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/191920
Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies Nov 12, 1998 Issued
Array ( [id] => 4323360 [patent_doc_number] => 06248934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Gene trap vectors' [patent_app_type] => 1 [patent_app_number] => 9/191652 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5243 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248934.pdf [firstpage_image] =>[orig_patent_app_number] => 191652 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/191652
Gene trap vectors Nov 12, 1998 Issued
Array ( [id] => 4181457 [patent_doc_number] => 06150170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same' [patent_app_type] => 1 [patent_app_number] => 9/126220 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14404 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150170.pdf [firstpage_image] =>[orig_patent_app_number] => 126220 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/126220
Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same Jul 29, 1998 Issued
09/116298 GENE TARGETING IN ANIMAL CELLS USING ISOGENIC DNA CONSTRUCTS Jul 14, 1998 Abandoned
Array ( [id] => 4271615 [patent_doc_number] => 06245747 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Targeted site specific antisense oligodeoxynucleotide delivery method' [patent_app_type] => 1 [patent_app_number] => 9/114399 [patent_app_country] => US [patent_app_date] => 1998-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12674 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245747.pdf [firstpage_image] =>[orig_patent_app_number] => 114399 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/114399
Targeted site specific antisense oligodeoxynucleotide delivery method Jul 12, 1998 Issued
09/096732 CHIMERIC TRANSCRIPTION FACTORS Jun 10, 1998 Abandoned
09/088766 USE OF A 1B1 INTEGRIN RECEPTOR BLOCKING AGENTS IN KIDNEY DIEASE Jun 1, 1998 Abandoned
Array ( [id] => 4275839 [patent_doc_number] => 06323390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Transgenic mouse models for human bladder cancer' [patent_app_type] => 1 [patent_app_number] => 9/083541 [patent_app_country] => US [patent_app_date] => 1998-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 27 [patent_no_of_words] => 13488 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323390.pdf [firstpage_image] =>[orig_patent_app_number] => 083541 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/083541
Transgenic mouse models for human bladder cancer May 21, 1998 Issued
09/071386 HOST DEFENSE ENHANCEMENT Apr 29, 1998 Abandoned
Menu